Skip to main content
SpringerLink
Log in

CZE Separation of New Drugs for Treatment of Leukemia

  • Published:
Chromatographia Aims and scope Submit manuscript

Abstract

Imatinib, bosutinib, dasatinib, pazopanib, erlotinib, canertinib and vatalanib are new developed anticancer drugs, especially for treatment of leukemia. In this article, a fast and high throughput capillary zone electrophoresis method has been developed and validated for analysis of these new drugs in pharmaceutical formulas. The method can be easily utilized for determination of all the drugs in one run what is advantageous for the quality control in pharmaceutical industry because there is no need for changing and optimization of separation conditions when changing the analyte. The separation was performed using an uncoated fused silica capillary with 100 mmol L−1 sodium phosphate buffer pH 2.75, voltage of 25 kV, hydrodynamic injection time of 5 s by 50 mbar, and detection at 214 nm. Under these conditions, the analysis took about 8 min. The validation of all the drugs resulted in recoveries in the range of 84–100 %. The method showed to be precise for all the drugs with RSDs of migration times lower than 0.9 % (interday precision). A very good linearity in the validated range (5–100 μg mL−1) and the limits of detection (LODs) in the range of 0.5–2.0 (μg mL−1) were achieved. Finally, we proved that the method is robust by the Youden’s test. Therefore, our method can be successfully applied for analysis of the real pharmaceutical samples.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  1. Kantarjian H, Sawyers Ch, Hochhaus A, Guilhot F, Schiffer Ch, Gambacorti-Passerini C, Niederwieser D, Resta D, Capdeville R, Zoellner U, Talpaz M, Druker B (2002) N Engl J Med 346:645–652

    Article  CAS  Google Scholar 

  2. Redaelli S, Piazza R, Rostagno R, Magistroni V, Perini P, Marega M, Gambacorti-Passerini C (2001) J Clin Oncol 27:469–471

    Article  Google Scholar 

  3. Khoury HJ, Cortes JE, Kantarjian HM, Gambacorti-Passerini C, Baccarani M, Dong-Wook K, Zaritskey A, Countouriotis A, Besson N, Leip E, Kelly V, Brümmendorf TH (2012) Blood 119:3403–3412

    Article  CAS  Google Scholar 

  4. Mičová K, Fridecký D, Faber E, Polýnková A, Adam T (2010) J Clin Chim Acta 411:1957–1962

    Article  Google Scholar 

  5. Li J, Huang Y, Huang L, Ye L, Zhou Z, Xiang G, Xu L (2012) J Pharm Biomed Anal 70:26–31

    Article  CAS  Google Scholar 

  6. Ajimura TO, Borges KB, Ferreira AF, Gastro FA, Gaitani CM (2011) Electrophoresis 32:1885–1892

    Article  CAS  Google Scholar 

  7. Druker BJ, Guilhot F, O’Brien SG, Gathmann I, Kantarjian H (2006) N Engl J Med 355:2408–2417

    Article  CAS  Google Scholar 

  8. Mandavilli A (2013) Nature 498:S1

    Article  CAS  Google Scholar 

  9. Elert E (2013) Nature 498:S2–S3

    Article  Google Scholar 

  10. DeWeerdt S (2013) Nature 498:S4–S6

    Article  CAS  Google Scholar 

  11. Sawyers ChL (2013) Nature 498:S7

    Article  CAS  Google Scholar 

  12. Katsnelson A (2013) Nature 498:S8–S97

    Article  Google Scholar 

  13. O’Brien SG, Guilhot F, Larson RA, Gathmann I, Baccarani M, Cervantes F, Cornelissen JJ, Fischer T, Hochhaus A, Hughes T, Lechner K, Nielsen JL, Rousselot P, Reiffers J, Saglio G, Shepherd J, Simonsson B, Gratwohl A, Goldman JM, Kantarjian H, Taylor K, Verhoef G, Bolton AE, Capdeville R, Druker BJ (2003) N Engl J Med 348:994–1004

    Article  Google Scholar 

  14. Deininger M, Buchdunger E, Druker BJ (2005) Blood 105:2640–2653

    Article  CAS  Google Scholar 

  15. Dziadosz M, Lessig R, Bartels H (2012) J Chromatogr B 893:77–81

    Article  Google Scholar 

  16. McCormack PL, Keam S (2011) Drugs 71:1771–1795

    Article  CAS  Google Scholar 

  17. Keisner SV, Shah SR (2011) Drugs 71:443–454

    CAS  Google Scholar 

  18. Joensuu H, De Braud F, Grignagni G, De Pas T, Spitalieri G, Coco P, Spreafico C, Boselli C, Toffalorio T, Bono P, Jalava T, Kappeler C, Aglietta M, Laurent D, Casali PG (2011) Brit J Cancer 104:1686–1690

  19. Yu HCh, Chen HJ, Chang YL, Liu ChY, Shiau ChW, Cheng AL, Chen KF (2013) Biochem Pharmacol 85:356–366

    Article  CAS  Google Scholar 

  20. Minocha M, Khurana V, Qin B, Pal D, Mitra AK (2012) Intern J Pharm 436:127–134

    Article  CAS  Google Scholar 

  21. Alia I, Haquea A, Wania WA, Saleema K, Zaabib MA (2013) Biomed Chromatogr 27:1296–1311

    Article  Google Scholar 

  22. Rosemana DS, Weinbergerb R (2013) J Pharm Biomed Anal 85:67–73

    Article  Google Scholar 

  23. Morzunova TG (2006) J Pharm Chem 40:158–170

    Article  CAS  Google Scholar 

  24. Altria KD, Frake P, Gill I, Hadgett T, Kelly MA, Rudd DR (1995) J Pharm Biomed Anal 13:951–957

    Article  CAS  Google Scholar 

  25. Yu K, Wang YW, Cheng YY (2006) Chromatographia 63:359–364

    Article  CAS  Google Scholar 

  26. Verma D, Kantarjian HM, Jones D, Luthra R, Borthakur G, Verstovsek S, Rios MB, Cortes J (2009) Blood 114:2232–2235

    Article  CAS  Google Scholar 

  27. Iacobucci I, Lonetti A, Cilloni D, Messa F, Ferrari A, Zuntini R, Ferrari S, Ottaviani E, Arruga F, Paolini S, Papayannidis C, Piccaluga PP, Soverini S, Saglio G, Pane F, Baruzzi A, Vignetti M, Berton G, Vitale A, Chiaretti S, Müschen M, Foà R, Baccarani M, Martinelli G (2008) Heamatology 93:1814–1821

    CAS  Google Scholar 

  28. Flores JR, Berzas JJ, Castaneda G, Rodriguez N (2003) J Chromatogr B 794:381–388

    Article  Google Scholar 

  29. http://www.chemaxon.com/products/marvin/marvinsketch Accessed 13 oct 2013

  30. Youden WJ, Steiner EH (1975) Statistical manual of AOAC—Association of Official Analytical Chemistry. AOAC, Washington, p 88

    Google Scholar 

Download references

Acknowledgments

The financial support of the research by the Operational Program Research and Development for Innovations—European Regional Development Fund (project CZ.1.05/2.1.00/03.0058), the Operational Program Education for Competitiveness—European Social Fund (project CZ.1.07/2.3.00/20.0018), the Grant Agency of the Czech Republic (project P206/12/1150), and the Student project UP Olomouc IGA_PrF_2014_031 is gratefully acknowledged.

Author information

Authors and Affiliations

  1. Department of Analytical Chemistry, Regional Centre of Advanced Technologies and Materials, Faculty of Science, Palacký University in Olomouc, 17. listopadu 12, Olomouc, CZ-77146, Czech Republic

    Jana Horská, Pavlína Ginterová, Juraj Ševčík & Jan Petr

Authors
  1. Jana Horská
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Pavlína Ginterová
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Juraj Ševčík
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Jan Petr
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Jan Petr.

Additional information

Published in the topical collection Advances in Chromatography and Electrophoresis & Chiranal 2014 with guest editor Jan Petr.

Electronic supplementary material

Below is the link to the electronic supplementary material.

Supplementary material 1 (PDF 440 kb)

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Horská, J., Ginterová, P., Ševčík, J. et al. CZE Separation of New Drugs for Treatment of Leukemia. Chromatographia 77, 1477–1482 (2014). https://doi.org/10.1007/s10337-014-2730-9

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10337-014-2730-9

Keywords

Search

Navigation